Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment

Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment

Abstract Effective antihypertensive therapy is essential for achieving optimal blood pressure (BP) control and reducing cardiovascular events. This double-blind, multicenter, randomized trial aimed to compare the antihypertensive efficacy and safety of a combination of amlodipine (AML) and candesart...

Full description

Bibliographic Details
Main Authors: Moon-Seung Soh, Kyung-heon Won, Jae-Joong Kim, Sung Yun Lee, Min Su Hyon, Ho-Joong Youn, Seung-Woon Rha, Doo-Il Kim, Youngkeun Ahn, Byung Jin Kim, Dong-Ju Choi, Jong-Seon Park, Dae-Kyung Kim, Woo-Jung Park, Hong-Seok Lim, Seung-Jea Tahk
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Scientific Reports
Subjects:
HTN
Amlodipine
Candesartan Cilexetil
Blood pressure
Angiotensin receptor blocker
Antihypertensive
Online Access:https://doi.org/10.1038/s41598-024-74003-5

Internet

https://doi.org/10.1038/s41598-024-74003-5

Similar Items